Jeffrey B. Kindler, a director at Precigen, Inc. ($PGEN), sold shares on the open market three times over the past year, totaling $1.46 million. His most recent sale occurred on December 12, 2025. These sales rank 4,109th among 11,678 insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. Kindler made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | M | Restricted Stock Units | 71839 | $0.00 | 0.0000 | 353,824,499 | 100.00% | 0.02% |
| March 13, 2026 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | M | Common Stock | 71839 | $0.00 | 202,100.0000 | 353,824,499 | 55.15% | 0.02% |
| March 10, 2026 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Restricted Stock Units | 35612 | $0.00 | 35,612.0000 | 353,824,499 | 9999.99% | 0.01% |
| March 10, 2026 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Common Stock | 19658 | $3.51 | 130,261.0000 | 353,824,499 | 17.77% | 0.01% |
| March 10, 2026 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Option to Purchase Common Stock (Right to Buy) | 41073 | $0.00 | 41,073.0000 | 353,824,499 | 9999.99% | 0.01% |
| Feb. 6, 2026 | Praxis Precision Medicines, Inc. | $PRAX | KINDLER JEFFREY B | Director | A | Common Stock | 688 | $0.00 | 688.0000 | 25,007,171 | 9999.99% | 0.00% |
| Feb. 6, 2026 | Praxis Precision Medicines, Inc. | $PRAX | KINDLER JEFFREY B | Director | A | Stock Option (Right to Buy) | 224 | $0.00 | 224.0000 | 25,007,171 | 9999.99% | 0.00% |
| Feb. 6, 2026 | Praxis Precision Medicines, Inc. | $PRAX | KINDLER JEFFREY B | Director | A | Common Stock | 478 | $0.00 | 1,166.0000 | 25,007,171 | 69.48% | 0.00% |
| Feb. 1, 2026 | Terns Pharmaceuticals, Inc. | $TERN | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| Dec. 12, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | S | Common Stock | 235467 | $3.63 | 110,603.0000 | 353,824,499 | 68.04% | 0.07% |
| Sept. 30, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | S | Common Stock | 106837 | $3.38 | 346,070.0000 | 294,042,973 | 23.59% | 0.04% |
| Sept. 29, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | S | Common Stock | 67523 | $3.60 | 452,907.0000 | 294,042,973 | 12.97% | 0.02% |
| June 11, 2025 | Terns Pharmaceuticals, Inc. | $TERN | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | M | Ordinary Shares | 9904 | $26.01 | 15,313.0000 | 137,400,000 | 183.10% | 0.01% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | F | Ordinary Shares | 4754 | $26.01 | 10,559.0000 | 137,400,000 | 31.05% | 0.00% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | A | Restricted Stock Units | 7305 | $0.00 | 7,305.0000 | 137,400,000 | 9999.99% | 0.01% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | M | Restricted Stock Units | 9904 | $0.00 | 0.0000 | 137,400,000 | 100.00% | 0.01% |
| March 14, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | M | Common Stock | 87412 | $0.00 | 520,430.0000 | 294,042,973 | 20.19% | 0.03% |
| March 14, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | M | Restricted Stock Units | 87412 | $0.00 | 0.0000 | 294,042,973 | 100.00% | 0.03% |
| March 13, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Option to Purchase Common Stock (Right to Buy) | 83517 | $0.00 | 83,517.0000 | 294,042,973 | 9999.99% | 0.03% |
| March 13, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Restricted Stock Units | 71839 | $0.00 | 71,839.0000 | 294,042,973 | 9999.99% | 0.02% |
| March 13, 2025 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Common Stock | 39655 | $1.74 | 433,018.0000 | 294,042,973 | 10.08% | 0.01% |
| Feb. 1, 2025 | Terns Pharmaceuticals, Inc. | $TERN | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 10657 | $0.00 | 10,657.0000 | 79,507,474 | 9999.99% | 0.01% |
| Dec. 9, 2024 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | S | Ordinary Shares | 17598 | $28.27 | 5,409.0000 | 137,500,000 | 76.49% | 0.01% |
| July 1, 2024 | Terns Pharmaceuticals, Inc. | $TERN | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 4676 | $0.00 | 4,676.0000 | 71,259,239 | 9999.99% | 0.01% |
| June 10, 2024 | Terns Pharmaceuticals, Inc. | $TERN | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | M | Ordinary Shares | 8764 | $30.22 | 27,214.0000 | 135,300,000 | 47.50% | 0.01% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | F | Ordinary Shares | 4207 | $30.22 | 23,007.0000 | 135,300,000 | 15.46% | 0.00% |
| May 14, 2024 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | A | Restricted Stock Units | 9904 | $0.00 | 9,904.0000 | 135,300,000 | 9999.99% | 0.01% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | M | Restricted Stock Units | 8764 | $0.00 | 0.0000 | 135,300,000 | 100.00% | 0.01% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Common Stock | 48251 | $1.43 | 393,363.0000 | 0 | 13.98% | 0.00% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Option to Purchase Common Stock (Right to Buy) | 101626 | $0.00 | 101,626.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | A | Restricted Stock Units | 87412 | $0.00 | 87,412.0000 | 0 | 9999.99% | 0.00% |
| March 9, 2024 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | M | Restricted Stock Units | 106837 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 9, 2024 | PRECIGEN, INC. | $PGEN | KINDLER JEFFREY B | Director | M | Common Stock | 106837 | $0.00 | 345,112.0000 | 0 | 44.84% | 0.00% |
| June 12, 2023 | Terns Pharmaceuticals, Inc. | $TERN | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | F | Ordinary Shares | 3734 | $32.86 | 18,450.0000 | 134,500,000 | 16.83% | 0.00% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | M | Restricted Stock Units | 7778 | $0.00 | 0.0000 | 134,500,000 | 100.00% | 0.01% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | M | Ordinary Shares | 7778 | $32.86 | 22,184.0000 | 134,500,000 | 53.99% | 0.01% |
| May 15, 2023 | PERRIGO Co plc | $PRGO | KINDLER JEFFREY B | Director | A | Restricted Stock Units | 8764 | $0.00 | 8,764.0000 | 134,500,000 | 9999.99% | 0.01% |